Regenxbio Free Cash Flow (Quarterly) Analysis

Regenxbio Inc (RGNX)

10.35 -0.79 (-7.09%) USD | NASDAQ | Nov 15, 11:53

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
September 30, 2024	-40.88M
June 30, 2024	-45.97M
March 31, 2024	-56.01M
December 31, 2023	-41.89M
September 30, 2023	-50.85M
June 30, 2023	-49.90M
March 31, 2023	-85.74M
December 31, 2022	-44.84M
September 30, 2022	-55.51M
June 30, 2022	-70.99M
March 31, 2022	-66.88M
December 31, 2021	326.88M
September 30, 2021	-61.20M
June 30, 2021	-55.91M
March 31, 2021	-75.07M
December 31, 2020	26.58M
September 30, 2020	-42.53M
June 30, 2020	-24.77M
March 31, 2020	-40.20M
December 31, 2019	-26.54M

Date	Value
September 30, 2019	-31.83M
June 30, 2019	-29.30M
March 31, 2019	-31.75M
December 31, 2018	-9.029M
September 30, 2018	-22.93M
June 30, 2018	67.54M
March 31, 2018	55.79M
December 31, 2017	-15.93M
September 30, 2017	-17.59M
June 30, 2017	-11.23M
March 31, 2017	-20.41M
December 31, 2016	-24.86M
September 30, 2016	-14.04M
June 30, 2016	-9.505M
March 31, 2016	-8.303M
December 31, 2015	-4.571M
September 30, 2015	-8.474M
June 30, 2015	-8.211M
March 31, 2015	-1.781M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-85.74M

Minimum

Mar 2023

326.88M

Maximum

Dec 2021

-29.11M

Average

-47.94M

Median

Free Cash Flow (Quarterly) Benchmarks